Lineage Cell Therapeutics's Earnings Outlook
Lineage Cell Therapeutics's Earnings Outlook
lineage cell therapeutics的收益前景
Lineage Cell Therapeutics (AMEX:LCTX) is gearing up to announce its quarterly earnings on Thursday, 2024-11-14. Here's a quick overview of what investors should know before the release.
lineage cell therapeutics (美交所:LCTX) 正在準備於2024年11月14日（週四）發佈其季度業績。以下是投資者在發佈前應該知道的快速概覽。
Analysts are estimating that Lineage Cell Therapeutics will report an earnings per share (EPS) of $-0.04.
分析師預計lineage cell therapeutics的每股收益（EPS）爲$-0.04。
Anticipation surrounds Lineage Cell Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
投資者對lineage cell therapeutics的公告充滿期待，希望能聽到超出預期的消息，並獲得下個季度的積極指引。
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
新投資者應該了解，儘管收益表現很重要，但市場反應往往受到指引的推動。
Past Earnings Performance
過去的盈利表現
The company's EPS beat by $0.01 in the last quarter, leading to a...
該公司在上個季度的每股收益...
登入免費觀看全文
登入/註冊
熱門討論
中概股財報季火熱：驚喜盈利能否延續漲勢？
1. 哪些行業可能成為本輪財報季的市場焦點？ 2. 在政府強調科技創新和可持續發展的背景下，你認為哪些行業具有最大的增長潜力？
Moomoo News Global
03/04 23:26
中國兩會：會議前後股票價格變動的關鍵要點